Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
10.32 Up 0.07(0.68%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 8,604   9,862   6,340   5,076  
Cost of Revenue -   -   -   -  
Gross Profit 8,604   9,862   6,340   5,076  
Operating Expenses
Research Development13,195  18,004  13,263  10,855  
Selling General and Administrative2,446  2,473  2,473  2,500  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,037) (10,615) (9,396) (8,279)
Income from Continuing Operations
Total Other Income/Expenses Net359  561  976  1,582  
Earnings Before Interest And Taxes(6,678)(10,054)(8,420)(6,697)
Interest Expense -   -   -   -  
Income Before Tax(6,678)(10,054)(8,420)(6,697)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,678)(10,054)(8,420)(6,697)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,678) (10,054) (8,420) (6,697)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (6,678) (10,054) (8,420) (6,697)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.